The Effect of Histopathologic Analysis and Tissue Cultures on Inpatient Management of Cellulitis and Pseudocellulitis
| Status: | Recruiting |
|---|---|
| Conditions: | Cosmetic |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 18 - 99 |
| Updated: | 12/26/2018 |
| Start Date: | May 25, 2018 |
| End Date: | June 1, 2019 |
| Contact: | Michelle A Pluta |
| Email: | michelle.pluta@osumc.edu |
| Phone: | 6146850251 |
The Investigators wish to study the value of dermatologic testing assessments in
differentiating between cellulitis and pseudocellulitis in the inpatient setting. The
Investigators propose that by utilizing cutaneous biopsies and tissue cultures in patients
that have been admitted to inpatient internal medicine teams, the investigators may be able
to improve multiple measures of hospital efficiency in patients presenting with
cellulitis-like symptoms, by more accurately recognizing cellulitis from pseudocellulitis.
The patient will undergo encrypted digital imaging for his or her condition. This image will
then be sent to the study investigators, along with basic clinical information on the skin
evaluation form. The study investigators will develop a differential diagnosis and then the
patient will undergo a skin biopsy. The patient will then be randomized to one of two arms
using a random number generator: A) Skin biopsies and tissue cultures recorded and published
in patient's medical chart as they would be in a standard of care procedure B) Skin biopsies
and tissue cultures consultation performed but not published in the patient's medical chart
unless medically necessary. Information will be collected from medical records in IHIS.
Patients will be contacted by phone 30 days after discharge.
differentiating between cellulitis and pseudocellulitis in the inpatient setting. The
Investigators propose that by utilizing cutaneous biopsies and tissue cultures in patients
that have been admitted to inpatient internal medicine teams, the investigators may be able
to improve multiple measures of hospital efficiency in patients presenting with
cellulitis-like symptoms, by more accurately recognizing cellulitis from pseudocellulitis.
The patient will undergo encrypted digital imaging for his or her condition. This image will
then be sent to the study investigators, along with basic clinical information on the skin
evaluation form. The study investigators will develop a differential diagnosis and then the
patient will undergo a skin biopsy. The patient will then be randomized to one of two arms
using a random number generator: A) Skin biopsies and tissue cultures recorded and published
in patient's medical chart as they would be in a standard of care procedure B) Skin biopsies
and tissue cultures consultation performed but not published in the patient's medical chart
unless medically necessary. Information will be collected from medical records in IHIS.
Patients will be contacted by phone 30 days after discharge.
Inclusion Criteria:
- admitted inpatient to The Ohio State University Wexner Medical Center Internal
Medicine ward with cellulitis-like symptoms, including but not limited to the
following: tenderness, redness, swelling, expansive lesion.
- Affecting one or more extremities
- are at least 90 days post any associated operation of the extremity
- are above the age of 18
- Participants will be patients with cellulitis or pseudocellulitis.
- Patients who have recurrent cellulitis will be eligible for enrollment into the study,
but only once.
Exclusion Criteria:
- Patients who are pregnant
- Prisoners
- Patients may not have trauma, ulcer, or puncture wound to the area
- May not be transferred from another hospital
- May not be admitted to the Cancer Hospital or with a known active solid organ or
hematologic cancer other than nonmelanoma skin cancer
We found this trial at
1
site
540 Officenter Place
Gahanna, Ohio 43230
Gahanna, Ohio 43230
Principal Investigator: Ben Kaffenberger, M.D.
Phone: 614-685-0251
Click here to add this to my saved trials
